Study of equivalence and comparable immunogenicity of biosimilar insulin aspart in comparison with the registered analogue
The increase in the prevalence of diabetes mellitus has accelerated significantly in recent years. The situation has been greatly complicated by the COVID-19 pandemic. On the one hand, diabetes mellitus is a risk factor for a severe course of infection, and on the other hand, COVID-19 increases the...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2022-06-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6913 |